These recommendations provide a data-supported approach to the diagnosis, staging and
treatment of patients diagnosed with hepatocellular carcinoma (HCC). They are based on …

Background Chemoembolization (TACE) improves survival in cirrhotic patients with
hepatocellular carcinoma (HCC). The optimal schedule, or whether embolization (TAE) …

Abstract Introduction The Asian Pacific Association for the Study of the Liver (APASL)
convened an international working party on the management of hepatocellular carcinoma …

Curative therapies for hepatocellular carcinoma (HCC), such as resection, liver
transplantation, and percutaneous ablation, can be applied in selected patients with early …

The recommendations provided in this document provide a data-supported approach to the
diagnosis, staging and treatment of patients diagnosed with hepatocellular carcinoma …

This randomized, controlled trial assessed the effect of transarterial embolization
(TAE)(without associated chemotherapy) on the survival of patients with nonsurgical …

PURPOSE: To elucidate major complications and their predisposing factors in transcatheter
oily chemoembolization (TOCE) for hepatic tumors. MATERIALS AND METHODS: In a …

A randomized trial of hepatic arterial chemoembolization was conducted in 42 patients with
unresectable hepatocellular carcinoma. These patients represented 41% of patients with …

Transcatheter arterial embolization (TAE) is widely used in the treatment of hepatic tumors. A
total of 2,300 TAE procedures were performed with a 2-15-mL injection of a mixture or …

BACKGROUND & AIMS: Transarterial chemoembolisation (TACE) is usually performed by
injecting an emulsion of a drug and iodised oil. Drug-eluting beads (DEBs) have undeniable …